Cyprotex Highlights - December 2022
December 19th 2022
Sit back and relax in the holidays and read our latest blog articles from the 2022 European Bioanalysis Forum:
- Is there a place for Echo-MS in high throughput ADME?
- Application of ultra-fast LC-MS/MS in DMPK screening
Research never stops at Cyprotex. Read on for a recap of some of our scientific content released this year.
New Publications:
- Studying the Right Transporter at the Right Time: An In Vitro Strategy for Assessing Drug-Drug Interaction Risk During Drug Discovery and Development
- Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow
- Nature Article: Transcriptomics Brings New Era of Toxicology Prediction
- Cyprotex ADME Guide, 5th Edition
New Posters:
- Comparing Basic Static Models for Predicting Clinical CYP3A4 Induction Risk
- Characterisation of Selective CYP46A1 Inhibitors and Activators
- Development of a High-Throughput Time Dependent Inhibition of CYP450 Assay in Cryopreserved Human Hepatocytes
- Impact of Time Point Sampling Methodology on HμREL® IVIVe
- Application of Acquity Premier Technology for Enhanced Chromatographic Performance
- High Content Screening and HT-RNA Sequencing using hiPSC-derived Cardiomyocytes
- High Throughput RNA-Seq Profiling of 3D Liver Organoids to Predict DILI
- In Vitro Assays to Predict Potential Immunotoxicology using Human PBMCs
- Identifying Seizures with Neuronal Models and MEA
Stream our popular webinar: Using Relative Induction Score to Improve Risk Assessment of Clinical CYP3A4 Induction, hosted by our in-house expert Katie Plant:
Read the latest news from parent company, Evotec:
- Exscientia announces CTA approval of a Phase I/II trial for EXS-21546, an A2A receptor antagonist co-developed with Evotec
- Evotec joins renewable energy heating network Toulouse Energie Durable (“TED”), substantially reducing its carbon emissions
- Evotec partner Kazia Therapeutics Limited announce the publication of positive pre-clinical data for EVT801
- Evotec announces further progress in neuroscience collaboration with Bristol Myers Squibb
Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:
.jpeg)
Close
Contact us to discuss your ADME Tox issues or request a quote
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
info@evotec.eu
or fill out the form below:
Close
Close
Download file
Close